Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Robert Wild has worked on the following 15 EPO patent applications which have been published in the last five years:

EP12174018

Pyrazolone-derivatives as PDE4 inhibitors

IPC classification:
A61K 31/444, A61P 1/00, A61P 11/00, A61P 17/00, C07D 401/14
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12190855

Method for preparation of a high concentration liquid formulation of an antibody

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
APPLICATION WITHDRAWN
EP12190793

Cross-flow ultrafiltration device and method for concentration of pharmaceutical compositions

IPC classification:
B01D 61/14, B01D 63/08
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
APPLICATION WITHDRAWN
EP12190838

Vent gases for use in drying, storing and/or reconstituting biomolecules

IPC classification:
A61K 9/19, A61K 38/00, A61K 39/00, A61K 47/18, A61K 47/26, B65B 31/00, C07K 16/28, F26B 5/06
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
APPLICATION WITHDRAWN
EP14164018

3,4,4a,10b-tetrahydro-1H-thiopyrano-[4,3-c]isoquinoline derivatives

IPC classification:
A61K 31/519, A61P 11/00, A61P 11/06, A61P 11/08, C07D 519/00
Applicant:
AstraZeneca AB
Applicant:
Takeda GmbH
Agent:
Tracy Anne Burns, AstraZeneca PLC
Agent:
Robert Wild, Takeda GmbH
Status:
PATENT GRANTED
EP12728453

NOVEL PHTHALAZINONE-PYRROLOPYRIMIDINECARBOXAMIDE DERIVATIVES

IPC classification:
A61K 31/519, A61P 11/00, C07D 487/04
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12729458

NOVEL 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO[4,3-C]ISOQUINOLINE COMPOUNDS

IPC classification:
A61K 31/519, A61P 11/00, C07D 495/04, C07D 519/00
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13724745

NOVEL EP2 RECEPTOR AGONISTS

IPC classification:
C07C 233/64, C07C 233/75
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
EXAMINATION REQUESTED
EP12196702

Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors

IPC classification:
A61K 31/473, A61P 3/10, A61P 11/00, A61P 11/06, A61P 17/00, A61P 17/06, C07D 401/04
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10790569

3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-C]ISOQUINOLINE DERIVATIVES

IPC classification:
A61K 31/519, A61P 11/00, A61P 11/06, A61P 11/08, C07D 519/00
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13791947

METHOD FOR PREPARATION OF A HIGH CONCENTRATION LIQUID FORMULATION OF AN ANTIBODY

IPC classification:
A61K 39/395, C07K 16/28
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
GRANT OF PATENT INTENDED
EP14710314

FORMULATION OF AN ANTIBODY AND USE THEREOF

IPC classification:
C07K 16/28
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
EXAMINATION REQUESTED
EP11741221

DEVICE AND SYSTEM FOR DELIVERY OF AN AEROSOL TO A PATIENT ON VENTILATORY SUPPORT

IPC classification:
A61M 16/06, A61M 16/14
Applicant:
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Applicant:
Takeda GmbH
Agent:
Herzog Fiesser & Partner Patentanwälte PartG mbB
Agent:
Robert Wild, Takeda GmbH
Status:
GRANT OF PATENT INTENDED
EP15700703

TREATMENT OF PARTLY CONTROLLED OR UNCONTROLLED SEVERE ASTHMA WITH A PDE4 INHIBITOR (AND IN COMBINATION WITH A LEUKOTRIENE MODIFIER)

IPC classification:
A61K 31/47, A61K 31/473, A61K 45/06, A61P 11/06
Applicant:
Takeda GmbH
Agent:
Robert Wild, Takeda GmbH
Status:
EXAMINATION REQUESTED
EP15708411

UTI FUSION PROTEINS

IPC classification:
A61K 38/17, C07K 14/81
Applicant:
Takeda GmbH
Applicant:
Takeda Pharmaceutical Company Limited
Agent:
Robert Wild, Takeda GmbH
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature